Review
Published on 11 Mar 2021
Ibrexafungerp, a Novel Oral Triterpenoid Antifungal in Development: Overview of Antifungal Activity Against Candida glabrata
in Fungal Pathogenesis
Frontiers in Cellular and Infection Microbiology
doi 10.3389/fcimb.2021.642358
- 22,688 views
- 50 citations




